Sonnet BioTherapeutics (SONN) Misses Q4 EPS by 31c
Tweet
Share
E-mailGet Alerts SONN Hot Sheet
Join SI Premium – FREE
Sonnet BioTherapeutics (NASDAQ: SONN) reported Q4 EPS of ($0.31).
For earnings history and earnings-related data on Sonnet BioTherapeutics (SONN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'
- HSBC Upgrades Bid Corp Ltd (BID:SJ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
